Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sundrug Co ( (JP:9989) ) has shared an update.
Sundrug Co., Ltd. announced it has received dividends totaling 6,176 million yen from its subsidiaries, DIREX CORPORATION and SEIKODO PHARMACY CO., LTD. This dividend income will be recorded as non-operating income in the company’s non-consolidated financial results for the fiscal year ending March 31, 2026, without affecting the consolidated financial results.
The most recent analyst rating on (JP:9989) stock is a Buy with a Yen4700.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. operates in the pharmaceutical and retail industry, focusing on providing healthcare products and services. It is listed on the Tokyo Stock Exchange and engages in the management of pharmacies and drugstores.
Average Trading Volume: 318,051
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen536.1B
Find detailed analytics on 9989 stock on TipRanks’ Stock Analysis page.